Developments in the Production of Recombinant Monoclonal Antibodies
Biotechnology Journal · 2025
DOI: 10.1002/biot.70127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Debajyoti Saha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biochemical Engineering Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Recombinant Proteins, Biotechnology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 212 Literaturangaben.
Abstract (Originalsprache)
Over the last three decades, recombinant monoclonal antibodies (mAbs) have emerged as highly promising therapeutics in the treatment and cure of chronic diseases, such as cancer, cardiovascular disease, autoimmune diseases, sexually transmitted diseases, neurological disorders, ophthalmologic disorders, viral neutralization, research reagents, and diagnostic tools. This has led to a rapid increase in the mAb market globally. Increased market demands have led researchers to develop hosts like mammalian cells, bacteria, fungi, yeast, insect cell lines, transgenic plants, and transgenic animals for increased mAb production. To surpass different challenges related to activity and production, different upstream strategies like antibody engineering, host cell engineering, media formulation, and bioreactor parameter optimization are being developed. The development of simple and low‐cost downstream techniques is also one of the most important steps in antibody production for making an economically feasible process and product. The present review aims to briefly discuss the history of mAb production and current strategies used for the development and production of recombinant mAbs on a larger scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemical Engineering Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India.
ORCID-Profile: Debajyoti Saha
Zitieren
APA
Saha, D., Das, P. K., & Veeranki, V. D. (2025). Developments in the Production of Recombinant Monoclonal Antibodies. Biotechnology Journal. https://doi.org/10.1002/biot.70127
Vancouver
Saha D, Das PK, Veeranki VD. Developments in the Production of Recombinant Monoclonal Antibodies. Biotechnology Journal. 2025. doi:10.1002/biot.70127
BibTeX
@article{Saha2025,
author = {Saha, Debajyoti and Das, Prabir Kumar and Veeranki, Venkata Dasu},
title = {Developments in the Production of Recombinant Monoclonal Antibodies},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70127}
}
EUVIMED